Drug prescription patterns in schizophrenia outpatients: Analysis of data from a German health insurance fund

Pharmacopsychiatry

Volumn 42, Issue 2, 2009, Pages 66-71

  Weinbrenner, S ^a   Assion, H J ^b   Stargardt, T ^a   Busse, R ^a   Juckel, G ^b   Gericke, C A ^a,c  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; BENZODIAZEPINE DERIVATIVE; PRESCRIPTION DRUG;

ADULT; ARTICLE; DATA ANALYSIS; FEMALE; FOLLOW UP; GERMANY; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA; CLINICAL PRACTICE; DRUG COMBINATION; ECONOMICS; MIDDLE AGED; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; OUTPATIENTS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; RISPERIDONE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; YOUNG ADULT;

EID: 67649197385     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1103293     Document Type: Article

References (28)

1. American Psychiatric Association. Practice guideline for treatment of patients with schizophrenia. Am J Psychiatry 2001 ; 154 : 1-63
2. Atik L, Erdogan A, Karaahmet E et al. Antipsychotic prescriptions in a university hospital outpatient population in Turkey: A retrospective database analysis, 2005 - 2006. Prog Neuropsychopharmacol Biol Psychiatry 2008 ; Epub ahead of print
3. Ballerini A, Boccalon RM, Boncompagnie G et al. Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units, the PERSEO (psychiatric emergency study and epidemiology) survey. Ann Gen Psychiatry 2007 ; 6 : 29
4. Bagnall AM, Jones L, Ginnelly L et al. A systematic review of atypical antipsychotic drugs in schizophrenia. Health Technol Assess 2003 ; 7 : 1-193
5. Bromet EJ, Fennig S. Epidemiology and natural history of schizophrenia . Biol Psychiatry 1999 ; 46 : 871-881
6. Clade H. Fallbeispiel Schizophrenie: Hohe soziale Kosten. Dt Ä rzteblatt 2003 ; 100A : 1924-1925
7. Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia . N Engl J Med 2002 ; 346 : 16-22
8. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of secondgeneration antipsychotics. Arch Gen Psychiatry 2003 ; 60 : 553-560
9. Dossenbach M, Arango-Davila C, Ibarra HS et al. Response and relapse in patients with schizophrenia treated with olanzapine, risperidone, quetiapine, or haloperidole: 12-month follow-up of the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) Study. J Clin Psychiatry 2005 ; 66 : 1021-1030
10. Essock SM, Hargreaves WA, Covell NH et al. Clozapine's effectiveness for patients in state hospitals: results from a randomized trial. Psychopharmacol Bull 1996 ; 32 : 683-697
11. Hamann J, Pfeifer H, Kissling W. Are patients with schizophrenia undertreated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists. Pharmacopsychiatry 2003 ; 36 : 309-312
12. Haro JM, Edgell ET, Frewer P et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) Study: baseline findings across country and treatment. Acta Psychiatr Scand 2003 ; 107 (Suppl. 416) : 7-15
13. Kissling W, Hoffl er J, Seemann U et al. Direct and indirect costs of schizophrenia. Fortschr Neurol Psychiat 1999 ; 67 : 29-36
14. Knapp M. Costs of schizophrenia. Br J Psychiatry 1997 ; 171 : 509-518
15. Liebermann JA, Stroup TS, MacEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005 ; 353 : 1209-1223
16. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994 ; 151 : 825-835
17. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997 ; 349 : 1498-1504
18. Rosenheck R, Perlick D, Bingham S et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA 2003 ; 290 : 2693-2702
19. Rosenheck RA. Effectiveness versus efficacy of second generation antipsychotics: Haloperidol without anticholinergics as a comparator. www.ps.psychiatryonline.org Accessed Oct 11th 2005
20. Schwabe U, Paffrath D eds. Arzneiverordnungsreport 2004. Berlin, Heidelberg: Springer ; 2004
21. Sernyak MJ, Leslie D, Rosenheck R. Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications. Am J Psychiatry 2003 ; 160 : 310-315
22. Tang YL, Mao PX, Jiang F. Clozapine in China. Pharmacopsychiatry 2008 ; 41 : 1-9
23. Tiihonen J, Wahlbeck K, L önnqvist J et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006 ; 333 : 224
24. Tollefson GD, Beasley JM, Tran PV. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective disorders and schizophreniforme disorders: results of an international collaborative trial. Am J Psychiatry 1997 ; 154 : 457-465
25. Weiden PJ, Kozma C, Grogg A et al. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 2004 ; 55 : 8 86-891
26. Whiteford H, Teeson M, Scheurer R et al Responding to the burden of mental illness. Commission for Macroeconomics and Health: Geneva ; 2001
27. World Health Organization. The World Health Report 2003. WHO: Geneva ; 2003
28. Xiang YT, Weng YZ, Leung CM. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia. Pharmacopsychiatry 2007 ; 40 : 47-52